Penn Heart & Vascular offers the HeartMate II® LVAD and the HeartWare® VAD for patients with advanced heart failure (ACCHA Stage D). Medical Director of the Ventricular Assist Device Program J. Eduardo Rame, MD, reveals how, with survival close to 70% at two years, these devices are quickly approaching standard of care for bridge-to-transplant and destination therapy at Penn Medicine.
Related Links
Published
May 9, 2014
Created by
BROADCASTMED